Concepedia

Megumi Oshima

MO

30

Publications

1.7K

Citations

19

H-Index

2018

Active since

Affiliations

Kanazawa University(Current)

Kanazawa Medical University

The George Institute for Global Health

The University of Sydney

Royal North Shore Hospital

Megumi Oshima is an author at Kanazawa University specializing in medicine, chronic kidney disease, and pharmacology.

ORCID

Top concepts

Publications per year

2018–2024

30

Publications

30

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial

Meg Jardine, Zien Zhou, Kenneth W. Mahaffey et al. · Journal of the American Society of Nephrology · 2020 · 172 citations · Full text

Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

Megumi Oshima, Brendon L. Neuen, Jingwei Li et al. · Journal of the American Society of Nephrology · 2020 · 163 citations · Full text

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Megumi Oshima, Meg Jardine, Rajiv Agarwal et al. · Kidney International · 2020 · 150 citations · Full text

Gut microbiota–derived D-serine protects against acute kidney injury

Yusuke Nakade, Yasunori Iwata, Kengo Furuichi et al. · JCI Insight · 2018 · 149 citations · Full text

, , +17

Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2

George L. Bakris, Megumi Oshima, Kenneth W. Mahaffey et al. · Clinical Journal of the American Society of Nephrology · 2020 · 131 citations · Full text

Rows per page

1–5 of 30